[DPHARMA] QoQ Cumulative Quarter Result on 31-Mar-2019 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-May-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Mar-2019 [#1]
Profit Trend
QoQ- -69.64%
YoY- 34.16%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 576,462 438,707 295,852 150,386 498,722 383,088 257,250 70.99%
PBT 70,809 56,870 37,102 18,786 59,666 42,008 26,170 93.82%
Tax -15,536 -13,630 -8,721 -4,321 -12,025 -8,736 -5,184 107.45%
NP 55,273 43,240 28,381 14,465 47,641 33,272 20,986 90.38%
-
NP to SH 55,273 43,240 28,381 14,465 47,641 33,272 20,986 90.38%
-
Tax Rate 21.94% 23.97% 23.51% 23.00% 20.15% 20.80% 19.81% -
Total Cost 521,189 395,467 267,471 135,921 451,081 349,816 236,264 69.21%
-
Net Worth 525,364 505,919 503,029 496,410 483,173 501,487 209,983 83.98%
Dividend
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Div 40,937 6,745 6,618 - 36,403 9,897 4,199 354.47%
Div Payout % 74.06% 15.60% 23.32% - 76.41% 29.75% 20.01% -
Equity
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Net Worth 525,364 505,919 503,029 496,410 483,173 501,487 209,983 83.98%
NOSH 684,383 680,106 661,881 661,881 661,881 661,881 650,902 3.39%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 9.59% 9.86% 9.59% 9.62% 9.55% 8.69% 8.16% -
ROE 10.52% 8.55% 5.64% 2.91% 9.86% 6.63% 9.99% -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 84.49 65.04 44.70 22.72 75.35 58.06 91.88 -5.42%
EPS 8.25 6.49 4.26 2.19 7.26 5.09 3.22 86.91%
DPS 6.00 1.00 1.00 0.00 5.50 1.50 1.50 151.34%
NAPS 0.77 0.75 0.76 0.75 0.73 0.76 0.75 1.76%
Adjusted Per Share Value based on latest NOSH - 661,881
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
RPS 59.93 45.61 30.76 15.63 51.85 39.82 26.74 71.00%
EPS 5.75 4.50 2.95 1.50 4.95 3.46 2.18 90.56%
DPS 4.26 0.70 0.69 0.00 3.78 1.03 0.44 352.38%
NAPS 0.5461 0.5259 0.5229 0.5161 0.5023 0.5213 0.2183 83.97%
Price Multiplier on Financial Quarter End Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 -
Price 1.42 1.40 1.37 1.28 0.95 1.23 1.30 -
P/RPS 1.68 2.15 3.06 5.63 1.26 2.12 1.41 12.35%
P/EPS 17.53 21.84 31.95 58.57 13.20 24.39 17.34 0.72%
EY 5.70 4.58 3.13 1.71 7.58 4.10 5.77 -0.80%
DY 4.23 0.71 0.73 0.00 5.79 1.22 1.15 137.71%
P/NAPS 1.84 1.87 1.80 1.71 1.30 1.62 1.73 4.18%
Price Multiplier on Announcement Date
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Date 13/02/20 29/11/19 30/08/19 21/05/19 18/02/19 28/11/18 26/11/18 -
Price 1.64 1.39 1.41 1.36 1.03 1.07 1.08 -
P/RPS 1.94 2.14 3.15 5.99 1.37 1.84 1.18 39.17%
P/EPS 20.24 21.68 32.88 62.23 14.31 21.22 14.41 25.34%
EY 4.94 4.61 3.04 1.61 6.99 4.71 6.94 -20.22%
DY 3.66 0.72 0.71 0.00 5.34 1.40 1.39 90.34%
P/NAPS 2.13 1.85 1.86 1.81 1.41 1.41 1.44 29.72%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment